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We read with interest the study reported by Rello and 
colleagues [1]. Th  e authors described the ﬁ  rst 32 docu-
mented patients with pandemic inﬂ   uenza A H1N1 
(PIAH1N1) virus infection hospitalized in an intensive 
care unit (ICU) in Spain. Twenty-four patients (75.0%) 
had refractory hypo  xemia and required advanced 
mechanical ventilation. Eight patients (33.3%) received 
noninvasive mechanical ventilation at ICU admission. Six 
of these patients (75%) required further orotracheal 
intubation and invasive mechanical ventilation and two 
(33%) died.
Non-invasive ventilation (NIV) is not recommended 
for patients with PIAH1N1 virus infection complicated 
by pneumonia, acute lung injury (ALI) or acute respira-
tory distress syndrome (ARDS) because although NIV 
temporarily improves oxygenation and reduces the work 
of breathing in these patients, it does not necessarily 
change the natural disease course. On the other hand, 
NIV may increase the risk of respiratory pathogen 
transmission [2] and there is not enough evidence to 
support the treatment of ALI/ARDS with NIV. To date, 
three studies have suggested that NIV has not been 
successful in critically ill patients with hypoxemic 
respiratory failure attributable to PIAH1N1 virus infec-
tion [1,3,4]. In these studies a total of 76 patients received 
NIV, but 64 (84.2%) of these patients required subsequent 
intubation and invasive ventilation.
Considering the high failure rate of NIV therapy in 
patients with PIAH1N1 virus infection and ALI/ARDS, 
the treatment of ARDS associated with the PIAH1N1 
virus infection should be based upon published, 
evidence-based guidelines for sepsis-associated ARDS. 
Standard lung-protective ventilation strategies are 
appropriate initially [2,5].
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Authors’ response
Alejandro Rodríguez, Ignacio Martin-Loeches, Jordi Rello; and the H1N1 SEMICYUC Working Group
We appreciate the interest of Dr Ñamendys-Silva and 
colleagues in our article [1] and their insightful obser-
vations regarding ventilator management of severe 
PIAH1N1 virus infection. We agree that NIV is not 
recommended for patients with respiratory failure due to 
PIAH1N1 virus infection. However, several points should 
be clariﬁ  ed. Use of NIV in ARDS remains controversial 
and the etiology of hypoxemia seems to be an important 
determinant of successful outcome. Our results describe 
our national clinical practice in the current pandemic and 
it is consistent with other reports [3,6]. Other authors have 
recently reported that, in centers with expertise on NIV, 
30% of patients with ARDS were treated with NIV as a 
ﬁ   rst-line intervention and 30 to 50% of these avoided 
orotracheal intubation [1,3,6]. Th   us, only a small number 
of patients with ARDS beneﬁ   ted from NIV in expert 
centers, always needing close monitoring in the ICU 
setting. In selected patients with milder presentation a 
conservative ventilator approach should be considered 
until additional data from 2009 PIAH1N1 is obtained.
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